These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 3307014)
1. Loss of the activity of human coagulation factor XII by a chymotrypsin-like protease activated in rat mast cells during degranulation with compound 48/80. Majima M; Tani Y; Katori M Thromb Res; 1987 Jun; 46(6):855-67. PubMed ID: 3307014 [TBL] [Abstract][Full Text] [Related]
2. Degradation of Hageman factor by chymotrypsin-like protease released from rat mast cells during degranulation. Majima M; Tani Y; Katori M Adv Exp Med Biol; 1989; 247A():487-92. PubMed ID: 2690590 [No Abstract] [Full Text] [Related]
3. Chymotrypsin- and trypsin-type serine proteases in rat mast cells: properties and functions. Kido H; Fukusen N; Katunuma N Arch Biochem Biophys; 1985 Jun; 239(2):436-43. PubMed ID: 3890754 [TBL] [Abstract][Full Text] [Related]
4. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions. Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394 [TBL] [Abstract][Full Text] [Related]
5. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor. Scott CF; Silver LD; Schapira M; Colman RW J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202 [TBL] [Abstract][Full Text] [Related]
6. Compound 48/80-induced secretion of histamine from rat peritoneal mast cells depends on a tryptase controlled step also leading to chymase activity. Vassimon CS; Rothschild AM Agents Actions; 1990 Apr; 30(1-2):150-2. PubMed ID: 1695438 [TBL] [Abstract][Full Text] [Related]
7. Mammalian chymotrypsin-like enzymes. Comparative reactivities of rat mast cell proteases, human and dog skin chymases, and human cathepsin G with peptide 4-nitroanilide substrates and with peptide chloromethyl ketone and sulfonyl fluoride inhibitors. Powers JC; Tanaka T; Harper JW; Minematsu Y; Barker L; Lincoln D; Crumley KV; Fraki JE; Schechter NM; Lazarus GG Biochemistry; 1985 Apr; 24(8):2048-58. PubMed ID: 3893542 [TBL] [Abstract][Full Text] [Related]
8. The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein. Ikari N; Sugo T; Fujii S; Kato H; Iwanaga S J Biochem; 1981 Jun; 89(6):1699-709. PubMed ID: 6912861 [TBL] [Abstract][Full Text] [Related]
9. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils. Matsunaga Y; Kido H; Kawaji K; Kamoshita K; Katunuma N; Ogura T Arch Biochem Biophys; 1994 Jul; 312(1):67-74. PubMed ID: 8031148 [TBL] [Abstract][Full Text] [Related]
10. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Imamura T; Dubin A; Moore W; Tanaka R; Travis J Lab Invest; 1996 May; 74(5):861-70. PubMed ID: 8642782 [TBL] [Abstract][Full Text] [Related]
11. Tryptase and chymase: comparison of extraction and release in two dog mastocytoma lines. Caughey GH; Lazarus SC; Viro NF; Gold WM; Nadel JA Immunology; 1988 Feb; 63(2):339-44. PubMed ID: 3127330 [TBL] [Abstract][Full Text] [Related]
12. Activation of factor XII and prekallikrein with polysaccharide sulfates and sulfatides: comparison with kaolin-mediated activation. Shimada T; Sugo T; Kato H; Yoshida K; Iwanaga S J Biochem; 1985 Feb; 97(2):429-39. PubMed ID: 2861197 [TBL] [Abstract][Full Text] [Related]
13. Studies on prekallikrein of bovine plasma. II. Activation of prekallikrein with proteinases and properties of kallikrein activated by bovine Hageman factor. Takahashi H; Nagasawa S; Suzuki T J Biochem; 1980 Jan; 87(1):23-34. PubMed ID: 6766924 [TBL] [Abstract][Full Text] [Related]
14. Surface activation of blood coagulation, fibrinolysis and kinin formation. Heimark RL; Kurachi K; Fujikawa K; Davie EW Nature; 1980 Jul; 286(5772):456-60. PubMed ID: 6447254 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. Griffin JH; Cochrane CG Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663 [TBL] [Abstract][Full Text] [Related]
16. Biological functions of serine proteases in the granules of rat mast cells. Katunuma N; Fukusen N; Kido H Adv Enzyme Regul; 1986; 25():241-55. PubMed ID: 3544704 [TBL] [Abstract][Full Text] [Related]
17. Substrate specificity of the chymotrypsin-like protease in secretory granules isolated from rat mast cells. Le Trong H; Neurath H; Woodbury RG Proc Natl Acad Sci U S A; 1987 Jan; 84(2):364-7. PubMed ID: 3540962 [TBL] [Abstract][Full Text] [Related]
18. Plasma contact system activation drives anaphylaxis in severe mast cell-mediated allergic reactions. Sala-Cunill A; Björkqvist J; Senter R; Guilarte M; Cardona V; Labrador M; Nickel KF; Butler L; Luengo O; Kumar P; Labberton L; Long A; Di Gennaro A; Kenne E; Jämsä A; Krieger T; Schlüter H; Fuchs T; Flohr S; Hassiepen U; Cumin F; McCrae K; Maas C; Stavrou E; Renné T J Allergy Clin Immunol; 2015 Apr; 135(4):1031-1043.e6. PubMed ID: 25240785 [TBL] [Abstract][Full Text] [Related]
19. Dextran-induced anaphylactoid reaction in man: altered reactivity of high molecular weight kininogen. Briseid G; Briseid K Acta Pharmacol Toxicol (Copenh); 1980 Aug; 47(2):119-26. PubMed ID: 6159774 [TBL] [Abstract][Full Text] [Related]
20. Abnormalities in the contact activation through factor XII in Fujiwara trait: a deficiency in both high and low molecular weight kininogens with low level of prekallikrein. Oh-ishi S; Ueno A; Uchida Y; Katori M; Hayashi H; Koya H; Kitajima K; Kimura I Tohoku J Exp Med; 1981 Jan; 133(1):67-80. PubMed ID: 6785899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]